Key Strategic Factors and Emerging Trends Shaping the Animal Therapeutics and Diagnostics Market

The animal therapeutics and diagnostics sector is on track for remarkable expansion, driven by advancements in veterinary medicine and rising investments. As the industry evolves, understanding its size, leading players, and emerging trends offers valuable insights into where this dynamic market is headed over the coming years.

Forecasted Market Size and Growth of the Animal Therapeutics and Diagnostics Market
The animal therapeutics and diagnostics market is anticipated to experience substantial growth, reaching a valuation of $72.41 billion by 2030. This surge represents a compound annual growth rate (CAGR) of 7.2%. Several factors are contributing to this upward trajectory, including an increasing demand for precision animal medicine, heightened investments aimed at innovating veterinary diagnostics, stronger emphasis on antimicrobial stewardship, the expansion of point-of-care (POC) testing, and growing expenditures on animal healthcare overall. Key trends shaping the market include rising interest in integrated therapeutics and diagnostics solutions, early disease detection strategies in animals, adoption of preventive healthcare measures, increased use of combination drug therapies, and broader acceptance of in-clinic diagnostic testing.

Download a free sample of the animal therapeutics and diagnostics market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10150&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Prominent Players in the Animal Therapeutics and Diagnostics Market
The market features a number of influential companies actively shaping its landscape. Leading organizations include Zoetis Inc., Boehringer Ingelheim Animal Health USA Inc., Virbac AH Inc., Ceva Animal Health Inc., Heska Corporation, IDEXX Laboratories Inc., Bayer Animal Health LLC, Merck & Co. Inc. Animal Health Division, Sanofi-Aventis Animal Health Inc., Elanco Animal Health Incorporated, IDvet, MSD Animal Health, Vetoquinol S.A., Phibro Animal Health Corporation, Dechra Pharmaceuticals PLC, Kindred Biosciences Inc., Neogen Corporation, Abaxis Inc., Pfizer Animal Health, Norbrook Laboratories Limited, BioNote Inc., Thermo Fisher Scientific Inc., QIAGEN N.V., and bioMérieux Inc.

Strategic Moves Enhancing Market Presence
A notable development occurred in October 2023 when Zomedica, a US-based veterinary health company, announced the acquisition of Qorvo Biotechnologies LLC (QBT). Although the purchase price was not disclosed, this acquisition enables Zomedica to integrate Qorvo's cutting-edge diagnostic technologies into its portfolio. QBT specializes in point-of-care diagnostic platforms and biosensing technologies that improve testing speed and accuracy in veterinary settings.

View the full animal therapeutics and diagnostics market report:
https://www.thebusinessresearchcompany.com/report/animal-therapeutics-and-diagnostics-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Emerging Innovations and Their Impact on the Animal Therapeutics and Diagnostics Industry
Leading companies in this sector are increasingly focusing on telemedicine platforms designed to elevate pet healthcare services. Telemedicine leverages telecommunications technologies such as video calls, phone consultations, and secure messaging to remotely diagnose, treat, and monitor animal patients. For example, in June 2023, Cargill Inc., a US food conglomerate, launched Zoonivet, a digital pet-care application. This telehealth solution connects pet owners with licensed veterinarians via video calls, making primary care more accessible and convenient. Zoonivet also plans to expand its offerings by including surgery, home diagnostics, medication supply, pet nutrition, and boarding services throughout key Indian markets.

Breakdown of Major Animal Therapeutics and Diagnostics Market Segments
The animal therapeutics and diagnostics market is categorized across several key segments:
1) Product Types: Therapeutics, Diagnostics, Medical Devices
2) Animal Types: Companion Animals, Livestock Animals
3) Distribution Channels: Retail, E-Commerce, Veterinary Distributors
4) End-Users: Veterinary Hospitals or Clinics, Diagnostic Laboratories, Homecare, and Other Users

Further subsegments include:
- Therapeutics: Pharmaceuticals, Biologics, and Medical or Therapy Devices
- Diagnostics: Point-of-Care Diagnostics and Laboratory Diagnostics
- Medical Devices: Surgical Devices, Wound Care Products, and Rehabilitation or Therapy Devices

This comprehensive segmentation provides a clear picture of the diverse product and service offerings within the market.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.